CD163 and neoplasm: Several markers such as MHCII, CD80, and iNOS have been identified as M1 subtype TAM that can prevent tumor progression, while other markers including CD163, IL‐10, and Arg1 are regarded as M2 subtype TAM that can promote GBM progression.7